Benjamin Li
Sep 22, 2011

Pfizer Taiwan appoints Leo Burnett as AOR

TAIPEI - Pfizer has appointed Leo Burnett to handle its creative business in Taiwan, believed to be worth over US$4 million, for the next two years.

Pfizer appoints Leo Burnett Taiwan as new creative AOR
Pfizer appoints Leo Burnett Taiwan as new creative AOR

The move follows intensive pitching that also involved Dentsu and decade-long incumbent ADK Taiwan.

Leo Burnett will be responsible for creative work for Pfizer's Centrum range (including Centrum Base, Centrum Junior, Centrum Silver, Centrum New Prenatl) and the Robitussin range (including Robitussin DM, Robitussin Syrup, Robitussin Day Night Cough, Cold & Flu F.C. Caplet, Robitussin Cough, Cold & Flu F.C. Caplets).

The agency said that the advertising spend for Centrum and Robitussin over the coming year would total $3.2 million and US$1 million, respectively. The appointment does not affect Pfizer's media planning and buying relationship with Carat in the market.

In the Chinese mainland, Pfizer China recently called a media pitch for its subsidiaries Pfizer Nutrition (PN) and Consumer Healthcare (PCH), attended by Carat, Maxus, PHD and ZenithOptimedia.

Carat is the incumbent on the PN business with ZenithOptimedia currently handling PCH Caltrate and Robitussin's media planning.

Carat and ZenithOptimedia currently split the clients' media buying accounts across various cities in China, taking roughly 50 per cent each.

Pfizer China's media business is believed to worth $77 million. Pfizer Nutrition's two infant milk formulas Wyeth Gold and Illuma are worth around $46 million combined, with Pfizer Consumer Healthcare's three brands Centrum, Caltrate and cough syrup brand Robitussin worth about $31 million.

 

Source:
Campaign China

Follow us

Top news, insights and analysis every weekday

Sign up for Campaign Bulletins

Related Articles

Just Published

21 hours ago

BYD closes 2024 on top, but can it sustain its EV ...

BRAND HEALTH CHECK: After outpacing Tesla and smashing 2024 sales records, BYD faces its toughest road yet. With 45% EU tariffs and a locked-out U.S. market, can the EV giant supercharge global ambitions or stall under trade barriers?

21 hours ago

Move and win roundup: Week of January 2, 2025

As 2025 kicks off, Campaign rounds up the first major people moves and business wins of the year. From leadership exits to new creative wins, catch all the latest updates in January's first edition.

22 hours ago

What's in, what's out: Marketing trends you need to ...

OUTLOOK 2025: A clear, concise and constantly updated guide for industry trends and predictions—all in one place. Check back often for the freshest updates.